Acute encephalitis secondary to an ovarian teratoma by See, A.T., Woo, Y.L., Crawford, R.

Ovarian tissue characterization in ultrasound: A Review by Acharya, U.R., Molinari, F., Sree, S.V., Swapna, G., Saba, L., Guerriero, S., Suri, J.S.

“…Ovarian cancer is the most common cause of death among gynecological malignancies. …”

Inhibitory effects of leaf extract of Apama tomentosa on ovarian cancer by Lee, I.L., Kanthimathi, M.S., Wiart, C., Malik, N.A., Kuppusamy, U.R.

“…This plant compound can potentially help to treat ovarian cancer.…”
Get full text

Identification of metabolites in the normal ovary and their transformation in primary and metastatic ovarian cancer by Fong, M.Y., McDunn, J., Kakar, S.S.

“…In this study, we characterized the metabolome of the human ovary and identified metabolic alternations that coincide with primary epithelial ovarian cancer (EOC) and metastatic tumors resulting from primary ovarian cancer (MOC) using three analytical platforms: gas chromatography mass spectrometry (GC/MS) and liquid chromatography tandem mass spectrometry (LC/MS/MS) using buffer systems and instrument settings to catalog positive or negative ions. …”

Establishing the cut off values of androgen markers in the assessment of polycystic ovarian syndrome by Nadaraja, R.N. Dineshinee, Sthaneshwar, Pavai, Razali, Nuguelis

“…Introduction: Hyperandrogenism remains as one of the key features in Polycystic Ovarian Syndrome (PCOS) and can be assessed clinically or determined by biochemical assays. …”

Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer by Bojesen, S.E., Pooley, K.A., Johnatty, S.E., Beesley, J., Michailidou, K., Tyrer, J.P., Edwards, S.L., Pickett, H.A., Shen, H.C., Smart, C.E., Hillman, K.M., Mai, P.L., Lawrenson, K., Stutz, M.D., Lu, Y., Karevan, R., Woods, N., Johnstonw, R.L., French, J.D., Chen, X.Q., Weischer, M., Nielsen, S.F., Maranian, M.J., Ghoussaini, M., Ahmed, S., Baynes, C., Bolla, M.K., Wang, Q., Dennis, J., McGuffog, L., Barrowdale, D., Lee, A., Healey, S., Lush, M., Tessier, D.C., Vincent, D., Bacot, F., Vergote, I., Lambrechts, S., Despierre, E., Risch, H.A., Gonzaalez-Neira, A., Rossing, M.A., Pita, G., Doherty, J.A., Alvarez, N., Larson, M.C., Fridley, B.L., Schoof, N., Chang-Claude, J., Cicek, M.S., Peto, J., Kalli, K.R., Broeks, A., Armasu, S.M., Schmidt, M.K., Braaf, L.M., Winterhoff, B., Nevanlinna, H., Konecny, G.E., Lambrechts, D., Rogmann, L., Guenel, P., Teoman, A., Milne, R.L., Garcia, J.J., Cox, A., Shridhar, V., Burwinkel, B., Marme, F., Hein, R., Sawyer, E.J., Haiman, C.A., Wang-Gohrke, S., Andrulis, I.L., Moysich, K.B., Hopper, J.L., Odunsi, K., Lindblom, A., Giles, G.G., Brenner, H., Simard, J., Lurie, G., Fasching, P.A., Carney, M.E., Radice, P., Wilkens, L.R., Swerdlow, A., Goodman, M.T., Brauch, H., Garcia-Closas, M., Hillemanns, P., Winqvist, R., Durst, M., Devilee, P., Runnebaum, I., Jakubowska, A., Lubinski, J., Mannermaa, A., Butzow, R., Omar, S.Z.

“…Using the Illumina custom genotyping array iCOG, we analyzed similar to 480 SNPs at the TERT locus in breast (n = 103,991), ovarian (n = 39,774) and BRCA1 mutation carrier (n = 11,705) cancer cases and controls. …”

The effect of starvation on haemolymph metabolites, fat body and ovarian development in Oxya japonica (Acrididae: Orthoptera) by Lim, S.J., Lee, S.S.

Identification of O-glycosylated proteins that are aberrantly excreted in the urine of patients with early stage ovarian cancer by Wai Mu, A.K., Lim, B.K., Hashim, Onn Haji, Shuib, Adawiyah Suriza

“…The present study was performed to identify O-glycosylated proteins that are aberrantly excreted in the urine of patients with early stage ovarian cancer (OCa). These urinary glycoproteins are potential biomarkers for early detection of OCa. …”
Get full text

Zerumbone inhibits interleukin-6 and induces apoptosis and cell cycle arrest in ovarian and cervical cancer cells by Abdelwahab, S.I., Abdul, A.B., Zain, Z.N., Hadi, A.H.

“…Therefore, the current study was designed to investigate the role of IL-6 and IL6 receptors in the cytotoxic effects of zerumbone in ovarian and cervical cancer cell lines (Caov-3 and HeLa, respectively). …”

Habitual physical activity reduces risk of ovarian cancer: a case-control study in southern China by Lee, A.H., Su, D., Pasalich, M., Wong, Y.L., Binns, C.W.

“…OBJECTIVE: To ascertain the relationship between habitual physical activity and the risk of ovarian cancer among southern Chinese women. METHOD: A case-control study was conducted in Guangzhou, Guangdong Province, during 2006-2008. …”

Profiling of serum and tissue high abundance acute-phase proteins of patients with epithelial and germ line ovarian carcinoma by Chen, Y., Lim, B., Peh, S., Abdul-Rahman, Puteri Shafinaz, Hashim, Onn Haji

Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer by Shen, H., Fridley, B.L., Song, H.L., Lawrenson, K., Cunningham, J.M., Ramus, S.J., Cicek, M.S., Tyrer, J., Stram, D., Larson, M.C., Kobel, M., Ziogas, A., Zheng, W., Yang, H.P., Wu, A.H., Wozniak, E.L., Woo, Y.L., Winterhoff, B., Wik, E., Whittemore, A.S., Wentzensen, N., Weber, R.P., Vitonis, A.F., Vincent, D., Vierkant, R.A., Vergote, I., Van Den Berg, D., Van Altena, A.M., Tworoger, S.S., Thompson, P.J., Tessier, D.C., Terry, K.L., Teo, S.H., Templeman, C., Stram, D.O., Southey, M.C., Sieh, W., Siddiqui, N., Shvetsov, Y.B., Shu, X.O., Shridhar, V., Wang-Gohrke, S., Severi, G., Schwaab, I., Salvesen, H.B., Rzepecka, I.K., Runnebaum, I.B., Rossing, M.A., Rodriguez-Rodriguez, L., Risch, H.A., Renner, S.P., Poole, E.M., Pike, M.C., Phelan, C.M., Pelttari, L.M., Pejovic, T., Paul, J., Orlow, I., Omar, S.Z., Olson, S.H., Odunsi, K., Nickels, S., Nevanlinna, H., Ness, R.B., Narod, S.A., Nakanishi, T., Moysich, K.B., Monteiro, A.N.A., Moes-Sosnowska, J., Modugno, F., Menon, U., McLaughlin, J.R., McGuire, V., Matsuo, K., Adenan, N.A.M., Massuger, L.F.A.G., Lurie, G., Lundvall, L., Lubinski, J., Lissowska, J., Levine, D.A., Leminen, A., Lee, A.W., Le, N.D., Lambrechts, S., Lambrechts, D., Kupryjanczyk, J., Krakstad, C., Konecny, G.E., Kjaer, S.K., Kiemeney, L.A., Kelemen, L.E., Keeney, G.L., Karlan, B.Y., Karevan, R., Kalli, K.R., Kajiyama, H., Ji, B.T., Jensen, A., Jakubowska, A.

“…HNF1B is overexpressed in clear cell epithelial ovarian cancer, and we observed epigenetic silencing in serous epithelial ovarian cancer, leading us to hypothesize that variation in this gene differentially associates with epithelial ovarian cancer risk according to histological subtype. …”

Large BRCA1 and BRCA2 genomic rearrangements in Malaysian high risk breast-ovarian cancer families by Kang, P., Mariapun, S., Phuah, S.Y., Lim, L.S., Liu, J., Yoon, Sook-Yee, Thong, M.K., Taib, N.A.M., Yip, C.H., Teo, Soo-Hwang

Use of Nonlinear Features for Automated Characterization of Suspicious Ovarian Tumors Using Ultrasound Images in Fuzzy Forest Framework by Acharya, U. Rajendra, Akter, Ayesha, Chowriappa, Pradeep, Dua, Sumeet, Raghavendra, U., Koh, Joel E. W., Tan, Jen Hong, Leong, Sook Sam, Vijayananthan, Anushya, Hagiwara, Yuki, Ramli, Marlina Tanty, Ng, Kwan Hoong

“…Ovarian cancer is one of the prime causes of mortality in women. …”

Appraising the role of previously reported risk factors in epithelial ovarian cancer risk: A Mendelian randomization analysis by Yarmolinsky, James, Relton, Caroline L., Lophatananon, Artitaya, Muir, Kenneth, Menon, Usha, Gentry-Maharaj, Aleksandra, Walther, Axel, Zheng, Jie, Fasching, Peter, Zheng, Wei, Woo, Yin Ling, Park, Sue K., Kim, Byoung-Gie, Choi, Ji-Yeob, Park, Boyoung, Davey Smith, George, Martin, Richard M., Lewis, Sarah J.

“…Background: Various risk factors have been associated with epithelial ovarian cancer risk in observational epidemiological studies. …”

Different altered stage correlative expression of high abundance acute-phase proteins in sera of patients with epithelial ovarian carcinoma by Chen, Yeng, Lim, Boon Kiong, Hashim, Onn Haji

“…Background: The general enhanced expression of alpha(1)-antichymotrypsin (ACT), clusterin (CLU), alpha(1)-antitrypsin (AAT), haptoglobin beta-chain (HAP), and leucine rich glycoprotein (LRG) in the sera of patients with epithelial ovarian carcinoma (EOCa) was recently reported. In the present study, we compared the expression of the serum acute-phase proteins (APPs) in the patients according to their stages of cancer. …”
Get full text

Genetic counseling for patients and families with hereditary breast and ovarian cancer in a developing Asian country: An observational descriptive study by Yoon, Sook Yee, Thong, Meow Keong, Mohd Taib, Nur Aishah, Yip, Cheng Har, Teo, Soo Hwang

“…Genetic counseling (GC) and genetic testing are vital risk management strategies in hereditary breast and ovarian cancer (HBOC) syndromes. Hitherto, cancer genetic testing amongst Asians has been described only in developed and high-income Asian countries. …”

Plagioneurin B, a potent isolated compound induces apoptotic signalling pathways and cell cycle arrest in ovarian cancer cells by Nordin, Noraziah, Majid, Nazia Abdul, Othman, Rozana, Omer, Fatima Abdelmutaal Ahmed, Nasharuddin, Muhammad Nazil Afiq, Hashim, Najihah Mohd

“…This study is therefore importance in finding the effective compound that may offer an alternative drug for ovarian cancer treatment.…”

Prolonging the interval from ovarian hyperstimulation to laparoscopic ovum pick-up improves oocyte yield, quality, and developmental competence in goats by Abdullah, Ramli, Ng, S.C., Chan, W.K., Liow, S.L., Wan-Khadijah, W.E., Rahman, A.

“…The objective was to evaluate the effect of the interval between ovarian hyperstimulation and laparoscopic ovum pick-Lip (LOPU) on quality and developmental competence of goat oocytes before and after in vitro maturation (IVM) and intracytoplasmic sperm injection (ICSI). …”

Patients with ovarian carcinoma excrete different altered levels of urine CD59, kininogen-1 and fragments of inter-alpha-trypsin inhibitor heavy chain H4 and albumin by Abdullah-Soheimi, S.S., Lim, B., Hashim, Onn Haji, Shuib, A.S.

“…CD59, kininogen-1 and fragments of ITIH4 and albumin may be used as complementary biomarkers in the development of new noninvasive protocols for diagnosis and screening of ovarian carcinoma.…”